McArthur et al., 2013)
Clin Cancer Res 11 : 49124922 Munster P, Marchion D, Bicaku E, Schmitt M, Lee JH, DeConti R, Simon G, Fishman M, Minton S, Garrett C, Chiappori A, Lush R, Sullivan D, Daud A (2007) Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis
However, some men develop a troubling side effect called gynecomastia, or male breast enlargement
Identifying Your Individual Needs Everyone's biochemistry is unique
Tissue sections were observed under a fluorescence microscope, and digital images were acquired